Bone metabolism in type 2 diabetes mellitus

Area of Science:

• Endocrinology
• Metabolic bone disease
• Diabetes mellitus

Background:

• Osteoporosis is a known complication of type 1 diabetes.
• The relationship between type 2 diabetes and bone health, specifically osteoporosis, is not well-established.
• Type 2 diabetes affects bone mineral density and remodeling markers.

Purpose of the Study:

• To investigate bone mineral density (BMD) and bone remodeling markers in post-menopausal women with type 2 diabetes.
• To determine if type 2 diabetes is associated with osteopenia or osteoporosis.
• To compare bone health parameters between type 2 diabetic women and a healthy control group.

Main Methods:

• Dual-energy X-ray absorptiometry (DXA) was used to measure bone mineral density at lumbar and femoral sites.
• Bone remodeling markers, including urinary calcium, hydroxyproline, and telopeptide, were measured.
• A cohort of 66 post-menopausal women with type 2 diabetes was compared to a control population.

Main Results:

• Diabetic subjects exhibited significantly higher femoral bone mineral density compared to controls.
• Lumbar bone mineral density did not differ significantly between groups.
• Markers of bone resorption, such as urinary calcium and hydroxyproline, were elevated in diabetic patients, while urinary crosslinks were higher in controls.

Conclusions:

• Osteoporosis is unlikely to be a direct complication of type 2 diabetes.
• Type 2 diabetes is associated with increased bone resorption, indicated by elevated osteoclastic activity markers.
• Metabolic changes in type 2 diabetes significantly influence bone remodeling processes.